Methylphenidate warnings updated

Prescribing information for methylphenidate is being updated following a review of the drug's safety conducted by the EMEA earlier this year.

The agency concluded that the benefits of medicines containing methylphenidate outweigh their risks when used to treat ADHD in children aged six years and above.

However, prescribing advice for these products has been updated to emphasise the need to screen and monitor for cardiovascular and psychiatric problems before and during treatment.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from intelog

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Ranitidine in short supply after contamination fears prompt precautionary recall

Ranitidine in short supply after contamination fears prompt precautionary recall

GPs have reported shortages of ranitidine following...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Alzhok and ranitidine oral soln.
Use our...

Excessive steroid dosing highlighted in inflammatory bowel disease

Excessive steroid dosing highlighted in inflammatory bowel disease

Some patients with Crohn's disease or ulcerative colitis...